1
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers
Condition(s):Lung Cancer, Nonsmall Cell; Lung Cancer Stage IV; Lung Cancer MetastaticLast Updated:February 29, 2024Recruiting